Drugs Archives - Page 29 of 66

KHN’s ‘What the Health?’: Covid and Kids

Can schools safely reopen before all teachers and staffers are vaccinated against covid? And what’s the best way to communicate that science — and scientific recommendations — change and evolve? Also, get ready for a redo of open enrollment for Affordable Care Act coverage, this time with help and outreach to find those eligible. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more.

Feb. 4, 2021

COVID-19

100 Million Covid Shots in 100 Days Doesn’t Get Us Back to Normal

President Joe Biden’s promise to reach this milestone is an important step forward in vaccine rollout. But it is only the beginning of the sweeping vaccination effort required.

By Victoria Knight

Feb. 3, 2021

COVID-19

When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers

The Johnson & Johnson vaccine that the FDA cleared Saturday was 66% effective overall in preventing moderate to severe covid, while the Pfizer and Moderna vaccines were more than 90% effective. But the numbers aren’t exactly comparable. And all three shots prevent hospitalization and death.

By Arthur Allen and Liz Szabo

Feb. 1, 2021

States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden

As president, Donald Trump encouraged states to bring in drugs from Canada, where prices are cheaper. It’s not clear if the new administration will follow suit.

By Phil Galewitz

Jan. 29, 2021

Podcast

KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

President Joe Biden signed a pair of health-related executive orders this week that would, among other things, reopen enrollment under the Affordable Care Act and start to reverse former President Donald Trump’s anti-abortion policies. Meanwhile, Congress remains bogged down with taking up the next round of covid-19 relief. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health policy stories of the week they think you should read, too.

Jan. 28, 2021

COVID-19

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

With U.S. cases skyrocketing, demand for Gilead’s dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.

By Sarah Jane Tribble

Jan. 27, 2021

COVID-19

Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster

Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.

By Liz Szabo, Sarah Jane Tribble, Arthur Allen, and Jay Hancock

Jan. 26, 2021

Biden Promise Tracker

Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?

KHN has teamed up with PolitiFact to track what becomes of President Joe Biden’s 2020 campaign promises over the next four years. As he moves into the West Wing, what are his chances of making progress on health care?

By Victoria Knight

Jan. 22, 2021

Are Public Health Ads Worth the Price? Not if They’re All About Fear

Public service announcements about drug use or other public health problems often fall short, public health marketing experts say, because they incite people’s worst fears rather than giving people solutions.

By Eric Berger

Jan. 19, 2021

Podcast

KHN’s ‘What the Health?’: On Capitol Hill, Actions Have Consequences

Several large business groups, including health industry organizations, are cutting off contributions to Republicans who voted against the certification of Joe Biden’s election even after riots shut down the Capitol on Jan. 6. Meanwhile, the outgoing Trump administration not only approved a Medicaid block grant for Tennessee, but also made it difficult for the incoming Biden administration to undo. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Victoria Knight about the latest KHN-NPR “Bill of the Month” episode.

Jan. 14, 2021

Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted

“Thaw. Rest 15 minutes. Do not shake. Do not refreeze.”Do not shake. Do not refreeze.” Moderna’s vaccine comes with complicated instructions. And both available vaccines are good for only six hours once the vial is open. So at day’s end, health workers are left to either throw out precious doses or get shots into any arm that’s available.

By Rachana Pradhan

Jan. 14, 2021

COVID-19

Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?

More than two dozen people who have received the new covid vaccines in U.S. hospitals and health centers suffered anaphylaxis, a potentially fatal allergic reaction. While such severe reactions are rare, experts warn that the drugstores and drive-thru clinics considered integral to the vaccine rollout must be prepared.

By JoNel Aleccia

Jan. 11, 2021

Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy

President Donald Trump made substantial changes to the nation’s health care system using executive branch authority. But reversing policies that Democrats oppose would take time and personnel resources, competing with other priorities of the new administration.

By Julie Rovner

Jan. 8, 2021

Podcast

KHN’s ‘What the Health?’: Georgia Turns the Senate Blue

Democratic victories in two runoff elections in Georgia will give Democrats control of the Senate starting Jan. 20, which means they will be in charge of both houses of Congress and the White House for the first time since 2010. Meanwhile, covid continues to run rampant while vaccine distribution lags. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Jan. 7, 2021

San Francisco Wrestles With Drug Approach as Death and Chaos Engulf Tenderloin

Covid-19, distrust of police and cheap narcotics have turned parts of the wealthy city into cesspools of filth and drug overdose. City officials and residents profoundly disagree on what needs to be done.

By Rachel Scheier

Jan. 7, 2021

COVID-19

Listen: How Operation Warp Speed Became a Slow Walk

KHN Editor-in-Chief Elisabeth Rosenthal discusses the bottlenecks in distributing covid vaccines on NPR's “On My Mind” podcast with host Diane Rehm.

Jan. 7, 2021

Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs

Most private insurance will be required to cover drugs, like Truvada, that offer protection against HIV infection, without making plan members share the cost.

By Michelle Andrews

Jan. 5, 2021

Children’s Hospitals Are Partly to Blame as Superbugs Increasingly Attack Kids

A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail seniors but are increasingly infecting kids. And the pandemic is making things worse.

By Laura Ungar

Jan. 4, 2021

Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

While many private insurers cap what members pay in health costs, Medicare does not. Democrats and Republicans in Congress have proposed annual limits ranging from $2,000 to $3,100. But there’s disagreement about how to pay for that cost cap.

By Harris Meyer

Jan. 4, 2021